Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TEZRULY

TERAZOSIN HYDROCHLORIDE

Standard Dose
EQ 1MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TEZRULY is listed in Drugs@FDA under application 218139 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TERAZOSIN HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 1MG BASE/ML Sponsor NOVITIUM PHARMA Submission history Latest submission status date: 2024-07-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview TEZRULY is listed in Drugs@FDA under application 218139 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TERAZOSIN HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 1MG BASE/ML Sponsor NOVITIUM PHARMA Submission history Latest submission status date: 2024-07-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.